In addition to breast and ovarian cancers, BRCA1/2 mutations increase risks for other cancer types, including pancreatic cancer, prostate cancer, and colorectal cancer (Varol et al., 2018). This evidence concerns the gene BRCA1 and ovarian carcinoma.